Q-Med settles dispute between US subsidiary Medicis and Genzyme Q-Med settles dispute between US subsidiary Medicis and Genzyme 15-Feb-2011 By Simon Pitman Sweden-based anti-aging provider Q-Med has forged a settlement between its US subsidiary Medicis Pharmaceutical and Genzyme over a patent infringement.